Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-25

Clinical Trial Update: Early Oxybutinin Treatment for Boys With Posterior Urethral Valves [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring early oxybutynin treatment in boys with posterior urethral valves is in early reporting with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • oxybutynin (oxybutynin)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Male Urogenital Diseases | Phase 2 | Status: UNKNOWN